12:57 PM EDT, 05/02/2024 (MT Newswires) -- Agios Pharmaceuticals ( AGIO ) shares rose about 1.7% in recent Thursday trading after the company reported a Q1 loss of $1.45 per diluted share, narrowing from $1.47 a year earlier.

Analysts polled by Capital IQ expected a loss of $1.65.

Revenue for the quarter ended March 31 was $8.2 million, up from $5.6 million a year earlier. Analysts surveyed by Capital IQ expected $8.4 million.

Price: 34.23, Change: +0.57, Percent Change: +1.69